Consensus THX Pharma

Stocks

ALTHX

FR0013286259

Biotechnology & Medical Research

Real-time Euronext Paris 20:17:28 12/11/2026 +04			5-day change	1st Jan Change
3.410 ^EUR	-2.57%		+4.60%	+59.35%

09-29	THX Pharma Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-02	THX Pharma Partnership Seeks Regulatory Clearance for Late-stage Juvenile Batten Disease Drug Trial	MT

Evolution of the Average Target: THX Pharma

Evolution of the Average Target - THX Pharma

Evolution of the Target Price: THX Pharma

Evolution of the Target Price - THX Pharma

Changes in Analyst Recommendations: THX Pharma

bf9b049b1.yK1nm1uj-Fex_Mre5Mq6rr_Ut6o1zDWuYpgOJ8oJCYc.l9gd3BzLoR_Uyv-djvrA5Oi_-J52jkeYDdE7Qv1RP8mN_AK2NeSICN2MuQ~3db822dcd8f05c1711e9d4bf5455c3a0

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	THX PHARMA			-	-	+65.71%
	WUXI APPTEC CO., LTD.					+36.07%
	ARGENX SE					+15.3%
	LONZA GROUP AG					+7.92%
	BEONE MEDICINES AG					+10.05%
	IQVIA HOLDINGS INC.					+13.61%
	REVOLUTION MEDICINES, INC.					+52.1%
	CELLTRION, INC.					+33.03%
	GENMAB A/S					+13.92%
	INSMED INCORPORATED					+60.81%
	Average					+30.85%
	Weighted average by Cap.					+24.75%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

3.500EUR

Average target price

5.800EUR

Spread / Average Target

+65.71%

High Price Target

5.800EUR

Spread / Highest target

+65.71%

Low Price Target

5.800EUR

Spread / Lowest Target

+65.71%

Analyst Consensus Detail

Analyst consensus - THX Pharma

Consensus revision (last 18 months)

Consensus revision (last 18 months) - THX Pharma

Stock Market
Stocks
ALTHX Stock
Consensus THX Pharma